SciClone Pharmaceuticals, Inc.
950 Tower Lane
Suite 900
Foster City,
CA 94404-2125
United States - Map
Phone: 650-358-3456
Fax: 650-358-3469
Web Site: http://www.sciclone.com
| SciClone Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cancer and infectious diseases in China and internationally. It provides ZADAXIN for the treatment of hepatitis B and hepatitis C, and certain cancers, as well as for use as a vaccine adjuvant. The companys products under development includes ZADAXIN, a thymalfasin, which is in Phase III clinical trials for the treatment of stage IV melanoma; RP101, which is in Phase II clinical trials for the treatment of pancreatic cancer; and SCV-07, which is in Phase II clinical trials for the treatment of hepatitis C virus and oral mucositis. It also holds Chinese marketing rights from Biocompatibles International plc. for DC Bead, a product for the treatment of liver cancer or hepatocellular carcinoma. The company was founded in 1989 and is headquartered in Foster City, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Friedhelm Blobel Ph.D.,
Chief Exec. Officer and Pres |
$
881.00K |
$
0 | Mr. Gary S. Titus C.P.A., 49
Chief Financial Officer and Sr. VP of Fin. |
$
42.00K |
$
0 | Mr. Hans P. Schmid , 57
Pres of SciClone Pharmaceuticals International Ltd and Managing Director of SciClone Pharmaceuticals International Ltd |
$
458.00K |
$
0 | Mr. Ivan B. Hui , 46
Principal Accounting Officer and Assistant VP of Fin. |
$
253.00K |
$
0 | Dr. Israel Rios M.D., 62
Chief Medical Officer and Sr. VP of Medical Affairs |
$
416.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.29% Nasdaq 
Profile
